혈관 폐쇄 기기 시장 : 규모, 점유율, 성장률, 시장 분석, 유형별, 용도별, 지역별 인사이트, 예측(2026-2034년)

Growth Factors of vascular closure devices (VCDs) Market

The global vascular closure devices (VCDs) market was valued at USD 2.11 billion in 2025 and is projected to grow from USD 2.28 billion in 2026 to USD 4.92 billion by 2034, registering a strong CAGR of 10.10% during 2026-2034. North America dominated the global market with a 43.30% share in 2025, supported by high healthcare expenditure, advanced hospital infrastructure, and rapid adoption of minimally invasive cardiovascular procedures.

Vascular closure devices are used to achieve hemostasis at arterial puncture sites following catheterization procedures such as angioplasty, angiography, and stent placements. Compared to manual compression, VCDs reduce hemostasis time, minimize complications, and enable early patient ambulation, making them increasingly preferred in interventional cardiology settings.

According to the National Institutes of Health, more than 1 million cardiac catheterization procedures are performed annually in the U.S. The growing number of such procedures significantly drives demand for vascular closure devices worldwide.

COVID-19 Impact

The COVID-19 pandemic negatively affected the market in 2020 due to postponement of elective cardiovascular procedures and reduced hospital visits. Healthcare systems prioritized pandemic management, leading to a temporary decline in interventional cardiology volumes and VCD demand.

However, with easing restrictions in late 2021 and increasing procedural volumes in 2022, the market recovered steadily. By 2023, procedure volumes returned to pre-pandemic levels, and sustained growth is expected throughout the 2026-2034 forecast period.

Market Trends

Introduction of Advanced Product Offerings

A prominent market trend is the development of advanced, bioresorbable, and sutureless closure devices to minimize complications such as inflammation, hematoma, and delayed hemostasis.

For example, in July 2021, Vivasure Medical Ltd. introduced PerQseal Blue, a fully bioresorbable, sutureless large-bore closure device for percutaneous cardiovascular procedures. Such innovations are enhancing procedural safety and expanding device adoption globally.

Increasing clinical trials, fundraising initiatives, and R&D investments are expected to accelerate technological advancements during the forecast period.

Market Growth Drivers

Rising Interventional Cardiology Procedures

The growing burden of cardiovascular diseases is a major driver. According to global disease statistics, ischemic heart disease affects over 244 million individuals worldwide. This surge increases demand for diagnostic and therapeutic catheter-based procedures, directly boosting VCD adoption.

Additionally, data from the Organisation for Economic Co-operation and Development shows rising angioplasty procedures across countries, including Mexico and Canada, reinforcing global procedural growth.

Economic and Clinical Benefits

VCDs provide hemostasis within approximately 5 minutes compared to more than 15 minutes with manual compression. They also reduce hospital stays and enable same-day discharge.

A study published by the National Health Service estimated potential annual savings of up to USD 5.6 million if closure devices replace manual compression. These economic advantages significantly strengthen product adoption.

Restraining Factors

Despite advantages, product recalls and safety concerns pose challenges. In April 2022, the U.S. Food and Drug Administration announced a recall of Cardinal Health's CELT ACD device due to hematoma formation risks. Sterility concerns and packaging defects also contribute to recalls, negatively affecting market confidence.

Additionally, complications such as pseudoaneurysm and arterial occlusion may restrict widespread adoption in certain clinical settings.

Segmentation Analysis

By Product Type

The market is segmented into plug-based and clip-based devices.

• Plug-based devices dominated with a 62.28% share in 2026, driven by strong reimbursement coverage and preference for collagen plug-based solutions.
• Clip-based devices, including suture-mediated systems, are expected to grow steadily due to large-bore access procedures such as EVAR and TAVI.

By Type

• The passive segment held 62.28% share in 2026, supported by increasing R&D initiatives.
• Active devices are projected to grow at a significant CAGR due to innovation in clip-based systems.

By Access Site

• The femoral segment accounted for 90.79% share in 2026, as the femoral artery remains the preferred access site.
• Radial access is growing due to increasing research for advanced radial compression devices.

By End User

• Hospitals & ASCs dominated with 75% share in 2026, owing to large patient volumes and strong infrastructure.
• Specialty clinics and research institutes contribute a growing share.

Regional Insights

North America

North America generated USD 0.91 billion in 2025 and continues to dominate. The U.S. market is projected to reach USD 0.94 billion by 2026, driven by advanced healthcare infrastructure and strong presence of key players.

Europe

Europe holds the second-largest share. The UK market is estimated to reach USD 0.10 billion by 2026, while Germany is projected to reach USD 0.13 billion by 2026.

Asia Pacific

Asia Pacific is projected to grow at the highest CAGR during 2026-2034. China is estimated to reach USD 0.18 billion by 2026, Japan USD 0.05 billion, and India USD 0.13 billion, driven by rising geriatric populations and growing cardiac procedure volumes.

Competitive Landscape

Key players include Terumo Corporation, Abbott, Teleflex Incorporated, Haemonetics Corporation, Cordis, and Vivasure Medical Ltd.

In February 2024, Terumo expanded its manufacturing facility in Puerto Rico to meet rising demand for Angio-Seal VCDs, strengthening its global footprint.

Conclusion

The global vascular closure devices market is set to expand significantly from USD 2.11 billion in 2025 to USD 4.92 billion by 2034, supported by rising cardiovascular procedures, strong clinical benefits over manual compression, technological advancements, and favorable reimbursement policies. While product recalls and safety concerns present challenges, increasing procedural volumes, bioresorbable innovations, and expanding healthcare access-especially in Asia Pacific-will sustain long-term growth through 2034.

Segmentation By Product Type

• Plug Based Devices
  • Sealant or Gel-based Devices
  • Collagen Plugs
• Clip Based Devices
  • Suturing Devices
  • Clip/Staple Devices

By Type

• Active
• Passive

By Access Site

• Femoral
• Radial
• Others

By End-user

• Hospitals & ASCs
• Specialty Clinics
• Others

By Region

• North America (By Product Type, By Type, By Access Site, By End-user, and By Country)
  • U.S.
  • Canada
• Europe ( By Product Type, By Type, By Access Site, By End-user, and By Country/Sub-Region)
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
• Asia Pacific ( By Product Type, By Type, By Access Site, By End-user, and By Country/Sub-Region)
  • Japan
  • China
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America ( By Product Type, By Type, By Access Site, By End-user, and By Country/Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa ( By Product Type, By Type, By Access Site, By End-user, and By Country/Sub-Region)
  • GCC
  • South Africa
• Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Diseases, Key Countries/Region, 2025
• 4.2. Global Vascular Closure Devices, By Puncture Size, 2025
• 4.3. Technological Advancements in Vascular Closure Devices
• 4.4. Key Industry Developments: Mergers, Acquisitions & Partnerships
• 4.5. New Product Launches, By Key Players
• 4.6. Pricing Analysis, By Key Players
• 4.7. Impact of COVID-19 on the Vascular Closure Devices Market

5. Global Vascular Closure Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Plug Based Devices
    • 5.1.1.1. Sealant or Gel-based Devices
    • 5.1.1.2. Collagen Plugs
  • 5.1.2. Clip Based Devices
    • 5.1.2.1. Suturing Devices
    • 5.1.2.2. Clip/Staple Devices
• 5.2. Market Analysis, Insights and Forecast - By Type
  • 5.2.1. Active
  • 5.2.2. Passive
• 5.3. Market Analysis, Insights and Forecast - By Access Site
  • 5.3.1. Femoral
  • 5.3.2. Radial
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Hospitals & ASCs
  • 5.4.2. Specialty Clinics
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Vascular Closure Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Plug Based Devices
    • 6.1.1.1. Sealant or Gel-based Devices
    • 6.1.1.2. Collagen Plugs
  • 6.1.2. Clip Based Devices
    • 6.1.2.1. Suturing Devices
    • 6.1.2.2. Clip/Staple Devices
• 6.2. Market Analysis, Insights and Forecast - By Type
  • 6.2.1. Active
  • 6.2.2. Passive
• 6.3. Market Analysis, Insights and Forecast - By Access Site
  • 6.3.1. Femoral
  • 6.3.2. Radial
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By End User
  • 6.4.1. Hospitals & ASCs
  • 6.4.2. Specialty Clinics
  • 6.4.3. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Vascular Closure Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Plug Based Devices
    • 7.1.1.1. Sealant or Gel-based Devices
    • 7.1.1.2. Collagen Plugs
  • 7.1.2. Clip Based Devices
    • 7.1.2.1. Suturing Devices
    • 7.1.2.2. Clip/Staple Devices
• 7.2. Market Analysis, Insights and Forecast - By Type
  • 7.2.1. Active
  • 7.2.2. Passive
• 7.3. Market Analysis, Insights and Forecast - By Access Site
  • 7.3.1. Femoral
  • 7.3.2. Radial
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By End User
  • 7.4.1. Hospitals & ASCs
  • 7.4.2. Specialty Clinics
  • 7.4.3. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.5.1. Germany
  • 7.5.2. U.K.
  • 7.5.3. France
  • 7.5.4. Italy
  • 7.5.5. Spain
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Vascular Closure Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Plug Based Devices
    • 8.1.1.1. Sealant or Gel-based Devices
    • 8.1.1.2. Collagen Plugs
  • 8.1.2. Clip Based Devices
    • 8.1.2.1. Suturing Devices
    • 8.1.2.2. Clip/Staple Devices
• 8.2. Market Analysis, Insights and Forecast - By Type
  • 8.2.1. Active
  • 8.2.2. Passive
• 8.3. Market Analysis, Insights and Forecast - By Access Site
  • 8.3.1. Femoral
  • 8.3.2. Radial
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By End User
  • 8.4.1. Hospitals & ASCs
  • 8.4.2. Specialty Clinics
  • 8.4.3. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.5.1. China
  • 8.5.2. Japan
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Vascular Closure Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Plug Based Devices
    • 9.1.1.1. Sealant or Gel-based Devices
    • 9.1.1.2. Collagen Plugs
  • 9.1.2. Clip Based Devices
    • 9.1.2.1. Suturing Devices
    • 9.1.2.2. Clip/Staple Devices
• 9.2. Market Analysis, Insights and Forecast - By Type
  • 9.2.1. Active
  • 9.2.2. Passive
• 9.3. Market Analysis, Insights and Forecast - By Access Site
  • 9.3.1. Femoral
  • 9.3.2. Radial
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By End User
  • 9.4.1. Hospitals & ASCs
  • 9.4.2. Specialty Clinics
  • 9.4.3. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Vascular Closure Devices Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Plug Based Devices
    • 10.1.1.1. Sealant or Gel-based Devices
    • 10.1.1.2. Collagen Plugs
  • 10.1.2. Clip Based Devices
    • 10.1.2.1. Suturing Devices
    • 10.1.2.2. Clip/Staple Devices
• 10.2. Market Analysis, Insights and Forecast - By Type
  • 10.2.1. Active
  • 10.2.2. Passive
• 10.3. Market Analysis, Insights and Forecast - By Access Site
  • 10.3.1. Femoral
  • 10.3.2. Radial
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By End User
  • 10.4.1. Hospitals & ASCs
  • 10.4.2. Specialty Clinics
  • 10.4.3. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.5.1. GCC
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Terumo Corporation
    • 11.2.1.1. Overview
    • 11.2.1.2. Products
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Abbott
    • 11.2.2.1. Overview
    • 11.2.2.2. Products
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Teleflex Incorporated
    • 11.2.3.1. Overview
    • 11.2.3.2. Products
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Cordis
    • 11.2.4.1. Overview
    • 11.2.4.2. Products
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Haemonetics Corporation
    • 11.2.5.1. Overview
    • 11.2.5.2. Products
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Vasorum Ltd.
    • 11.2.6.1. Overview
    • 11.2.6.2. Products
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. INVAMED
    • 11.2.7.1. Overview
    • 11.2.7.2. Products
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Vivasure Medical Ltd.
    • 11.2.8.1. Overview
    • 11.2.8.2. Products
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)